Advanced lung cancer is notoriously hard to treat, but a team of Japanese scientists reports that a cancer drug known as Iressa was significantly more effective than standard chemotherapy for patients with a certain genetic profile. 众所周知晚期肺癌是很难治疗的，但日本科学家的报告称一种叫做易瑞沙的癌症药物治疗具有某种遗传特征的患者比标准化疗更为有效。
These patients have an advanced form of the most common type of lung cancer -- non-small cell lung cancer -- and a mutation of a protein found on the surface of certain cells that causes them to divide. This protein -- known as epidermal growth factor receptor (EGFR) -- is found in unusually high numbers on the surface of some cancer cells. 在这些肺癌患者都具有一个共同的特征—非小细胞肺癌—某些细胞表面的蛋白质的变异。这种蛋白—称为表皮生长因子受体 (EGFR) —是在一些的癌细胞的异常高数字的表面上找到的。
易瑞沙、特罗凯、格列卫，
印度抗癌药邮购中心版权所有
。官方网址：www.india-anticancer.com
|
